Switch to:
More From Other Websites
Bristol-Myers/AbbVie Cancer Drug Gets Priority Review Sep 02 2015
Is Novo Nordisk (NVO) an Incredible Growth Stock? 3 Reasons Why It Will Be Tough to Beat Aug 31 2015
Now the work starts for Novo Nordisk in Clayton Aug 28 2015
Research and Markets: China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk Aug 28 2015
Coverage initiated on Novo Nordisk A/S by Leerink Partners Aug 28 2015
Novo Nordisk to Start PIONEER Program on Semaglutide Aug 27 2015
Effective obesity management: It's more than reducing numbers on the scale Aug 27 2015
Effective obesity management: It's more than reducing numbers on the scale Aug 27 2015
Novo Nordisk adding diabetes drug output in NC, Denmark Aug 26 2015
Novo Nordisk adding diabetes drug output in NC, Denmark Aug 26 2015
Nearly 700 N.C. jobs announced as part of $1.2B Novo Nordisk expansion Aug 26 2015
Emisphere Highlights Eligen Licensee Novo Nordisk's Entry Into Phase 3a Development of Oral... Aug 26 2015
Emisphere Highlights Eligen Licensee Novo Nordisk's Entry Into Phase 3a Development of Oral... Aug 26 2015
Novo Nordisk A/S Q2 Earnings Analysis: By the Numbers, 2015 Aug 24 2015
Novo May Benefit From Possible Shire-Baxalta Disruption Aug 14 2015
Biggest Insulin Maker May Build Next Diabetes Drug Plant in U.S. Aug 14 2015
Moody's: Accelerated growth expected for EMEA Pharmaceuticals in 2016 Aug 11 2015
Novo Nordisk's Net Income Up Y/Y, 2015 Outlook Maintained - Analyst Blog Aug 07 2015
We want to be seen as Chinese: Novo Nordisk Aug 06 2015
China gets tougher for Western drugmakers Aug 06 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

Gintaras58
ReplyGintaras58 - 1 year ago
few excellent prducts to come soon


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK